Medicare Enrolled
Dr. Amit Patel, MD
Hematology & Oncology · Jersey City, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Amit Patel is a hematology & oncology specialist in Jersey City, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 43,946 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $645,847 from 79 pharmaceutical and/or device companies across 1074 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 22% volume in NJ
$645,847 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗43,946
Medicare services
Top 22% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
20,100 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,000 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,819 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 1,016 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
709 | $8 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
580 | $7 | $23 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
433 | $26 | $101 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
393 | $107 | $421 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
209 | $58 | $230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
188 | $12 | $48 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
170 | $110 | $463 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
132 | $142 | $590 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
77 | $18 | $98 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
41 | $1 | $6 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
29 | $12 | $53 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
25 | $6 | $13 |
| New patient office visit, complex (60-74 min) | 25 | $193 | $718 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
42.8% high complexity
53.0% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$645,847
Total received (2018-2024)
Avg $92,264/year across 7 years
Top 0% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,074
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$163,613
2023
$83,745
2022
$87,669
2021
$108,846
2020
$78,301
2019
$82,109
2018
$41,564
Payments by company (2024)
Daiichi Sankyo Inc.
$66,938
AstraZeneca Pharmaceuticals LP
$54,747
Incyte Corporation
$33,258
JAZZ PHARMACEUTICALS INC.
$8,099
GlaxoSmithKline, LLC.
$55
Blueprint Medicines Corporation
$41
Merck Sharp & Dohme LLC
$39
ARRAY BIOPHARMA INC
$38
Lilly USA, LLC
$35
Adaptive Biotechnologies Corporation
$33
Dendreon Pharmaceuticals LLC
$31
Janssen Biotech, Inc.
$29
Aveo Pharmaceuticals, Inc.
$26
Mirati Therapeutics, Inc.
$25
Novartis Pharmaceuticals Corporation
$25
Exelixis Inc.
$22
Pharmacosmos Therapeutics Inc.
$20
PFIZER INC.
$18
BeiGene USA, Inc.
$18
Astellas Pharma US Inc
$18
Octapharma USA, Inc.
$17
Genentech USA, Inc.
$17
Celgene Corporation
$17
PUMA BIOTECHNOLOGY, INC.
$16
E.R. Squibb & Sons, L.L.C.
$16
Ipsen Biopharmaceuticals, Inc
$15
Top 3 companies account for 94.7% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$194,922
Celgene Corporation
$166,954
Incyte Corporation
$120,001
AstraZeneca Pharmaceuticals LP
$96,869
JAZZ PHARMACEUTICALS INC.
$33,000
E.R. Squibb & Sons, L.L.C.
$12,129
Amgen Inc.
$5,794
Novocure Inc.
$5,699
CTI BioPharma Corp.
$2,538
Novartis Pharmaceuticals Corporation
$1,156
Janssen Biotech, Inc.
$610
Merck Sharp & Dohme Corporation
$516
Astellas Pharma US Inc
$368
PFIZER INC.
$359
Exelixis Inc.
$332
Seagen Inc.
$314
Lilly USA, LLC
$244
EMD Serono, Inc.
$233
Genentech USA, Inc.
$233
Pharmacyclics LLC, An AbbVie Company
$218
Blueprint Medicines Corporation
$169
NOVARTIS PHARMACEUTICALS CORPORATION
$167
GENZYME CORPORATION
$165
Bayer HealthCare Pharmaceuticals Inc.
$155
BeiGene USA, Inc.
$145
Gilead Sciences, Inc.
$142
Mallinckrodt Hospital Products Inc.
$125
Karyopharm Therapeutics Inc.
$125
ABBVIE INC.
$122
GlaxoSmithKline, LLC.
$120
Bausch & Lomb, a division of Bausch Health US, LLC
$119
Sunovion Pharmaceuticals Inc.
$117
Merck Sharp & Dohme LLC
$99
Medtronic, Inc.
$93
Regeneron Healthcare Solutions, Inc.
$88
EISAI INC.
$80
Kite Pharma, Inc.
$79
GE HealthCare
$75
Myovant Sciences Inc.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$57
Kyowa Kirin, Inc.
$56
Teva Pharmaceuticals USA, Inc.
$54
Janssen Pharmaceuticals, Inc
$51
Eisai Inc.
$47
Ipsen Biopharmaceuticals, Inc
$47
Otsuka America Pharmaceutical, Inc.
$44
Mirati Therapeutics, Inc.
$43
Epizyme, Inc.,
$41
Roche Diagnostics Corporation
$39
Pharmacosmos Therapeutics Inc.
$39
ARRAY BIOPHARMA INC
$38
Dova Pharmaceuticals
$36
Octapharma USA, Inc.
$35
Adaptive Biotechnologies Corporation
$33
Dendreon Pharmaceuticals LLC
$31
TESARO, Inc.
$28
Aveo Pharmaceuticals, Inc.
$26
AVEO Pharmaceuticals, Inc.
$25
Puma Biotechnology, Inc.
$24
Myriad Genetic Laboratories, Inc.
$21
Sumitomo Pharma America, Inc.
$18
Agios Pharmaceuticals, Inc.
$18
Genmab U.S., Inc.
$17
MACROGENICS, INC.
$16
Rigel Pharmaceuticals, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Coherus Biosciences Inc.
$16
Foundation Medicine, Inc.
$15
Seattle Genetics, Inc.
$15
TerSera Therapeutics LLC
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
TG THERAPEUTICS, INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Cerapedics, Inc.
$14
Horizon Therapeutics plc
$14
Alexion Pharmaceuticals, Inc.
$14
Global Blood Therapeutics, Inc.
$14
Acceleron Pharma, Inc.
$14
AbbVie Inc.
$13
Top 3 companies account for 74.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADAKVEO · ADCETRIS · ALIMTA · AVSOLA · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BENDEKA · BIOTRUE ONE DAY · BOSULIF · BRUKINSA · Balversa · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DIS Navify Software · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · GAZYVA · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kerendia · Kyprolis · LIBTAYO · LONHALA MAGNAIR · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONOFERRIC · Mavenclad · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Onivyde · Optune · PADCEV · PANZYGA · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · QUZYTTIR · REBLOZYL · RYDAPT · Reblozyl · Revlimid · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · Truxima · UKONIQ · Udenyca · VENCLEXTA · VERZENIO · VISUALASE · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ · i-FACTOR Putty · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
735
County median income
$90,032
Nearest hospital to ZIP centroid (approximate)
JERSEY CITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 22% in NJ), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Patel performed 20,100 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $645,847 from 79 companies across 1,074 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncology specialists in Jersey City?
Dr. Patel's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jersey City
Browse hematology & oncology specialists in Jersey City ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology